상세 보기
- Kim, Hwa-Ryeon;
- Yim, Juhye;
- Yoo, Hye-Been;
- Lee, Seung Eon;
- Oh, Sumin;
- ... Yoo, Kyung Hyun;
- 외 7명
WEB OF SCIENCE
0SCOPUS
0초록
Cancer cells utilize epigenetic alterations to acquire autonomous capabilities for tumor maintenance. Here, we show that pancreatic ductal adenocarcinoma (PDA) cells utilize super-enhancers (SEs) to activate the transcription factor EVI1 (ecotropic viral integration site 1) gene, resulting in activation of an EVI1-dependent transcription program conferring PDA tumorigenesis. Our data indicate that SE is the vital cis-acting element to maintain aberrant EVI1 transcription in PDA cells. Consistent with disease progression and inferior survival outcomes of PDA patients, we further show that EVI1 upregulation is a major cause of aggressive tumor phenotypes. Specifically, EVI1 promotes anchorage-independent growth and motility in vitro and enhances tumor propagation in vivo. Mechanistically, EVI1-dependent activation of tumor-promoting gene expression programs through the stepwise configuration of the active enhancer chromatin attributes to these phenotypes. In sum, our findings support the premise that EVI1 is a crucial driver of oncogenic transcription programs in PDA cells. Further, we emphasize the instructive role of epigenetic aberrancy in establishing PDA tumorigenesis.
- 제목
- EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer
- 저자
- Kim, Hwa-Ryeon; Yim, Juhye; Yoo, Hye-Been; Lee, Seung Eon; Oh, Sumin; Jung, Sungju; Hwang, Chang-il; Shin, Dong-Myung; Kim, TaeSoo; Yoo, Kyung Hyun; Kim, You-Sun; Lee, Han-Woong; Roe, Jae-Seok
- 발행일
- 2021-06
- 저널명
- NAR Cancer
- 권
- 3
- 호
- 2
- 페이지
- 1 ~ 15